Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2019 | 329 | 0.950 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2021 | 450 | 0.660 |
Why?
|
Piperidines | 1 | 2024 | 1649 | 0.500 |
Why?
|
Mycoses | 1 | 2018 | 387 | 0.500 |
Why?
|
Ipratropium | 1 | 2013 | 19 | 0.450 |
Why?
|
Antifungal Agents | 1 | 2018 | 745 | 0.450 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 822 | 0.430 |
Why?
|
Colitis, Ulcerative | 1 | 2024 | 1921 | 0.390 |
Why?
|
Pyrimidines | 1 | 2024 | 2996 | 0.390 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2019 | 12268 | 0.360 |
Why?
|
Bronchodilator Agents | 1 | 2013 | 506 | 0.340 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1672 | 0.320 |
Why?
|
Fractures, Bone | 1 | 2019 | 2035 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2286 | 0.270 |
Why?
|
Antirheumatic Agents | 3 | 2020 | 1372 | 0.230 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 2253 | 0.220 |
Why?
|
Propensity Score | 3 | 2021 | 1915 | 0.220 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1676 | 0.200 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2018 | 1376 | 0.180 |
Why?
|
Hydrochlorothiazide | 1 | 2021 | 94 | 0.180 |
Why?
|
Narcolepsy | 1 | 2023 | 199 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2024 | 4360 | 0.180 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 1400 | 0.160 |
Why?
|
Filgrastim | 1 | 2018 | 132 | 0.160 |
Why?
|
Hematologic Agents | 1 | 2018 | 41 | 0.160 |
Why?
|
Oseltamivir | 1 | 2018 | 77 | 0.150 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2063 | 0.150 |
Why?
|
Photosensitizing Agents | 1 | 2021 | 608 | 0.140 |
Why?
|
Incidence | 5 | 2024 | 21336 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2024 | 1128 | 0.130 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 559 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1870 | 0.130 |
Why?
|
Asthma | 1 | 2013 | 6161 | 0.120 |
Why?
|
Risk Factors | 7 | 2024 | 74167 | 0.110 |
Why?
|
Glucosides | 1 | 2018 | 536 | 0.110 |
Why?
|
Neutropenia | 1 | 2018 | 884 | 0.110 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 1187 | 0.110 |
Why?
|
Thromboembolism | 1 | 2019 | 1012 | 0.100 |
Why?
|
Electronic Prescribing | 1 | 2013 | 114 | 0.100 |
Why?
|
Benzhydryl Compounds | 1 | 2018 | 942 | 0.100 |
Why?
|
Sex Factors | 3 | 2021 | 10518 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 2018 | 1058 | 0.090 |
Why?
|
Biological Products | 1 | 2020 | 914 | 0.090 |
Why?
|
Rheumatic Diseases | 1 | 2017 | 639 | 0.090 |
Why?
|
Crohn Disease | 1 | 2022 | 2276 | 0.090 |
Why?
|
Electronic Health Records | 2 | 2024 | 4737 | 0.090 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2024 | 2420 | 0.080 |
Why?
|
SEER Program | 3 | 2019 | 1531 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2021 | 3060 | 0.080 |
Why?
|
Cohort Studies | 2 | 2024 | 41247 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2020 | 21988 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2018 | 1395 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2024 | 80121 | 0.080 |
Why?
|
Male | 15 | 2024 | 358719 | 0.080 |
Why?
|
Humans | 21 | 2024 | 759255 | 0.080 |
Why?
|
Medical Order Entry Systems | 1 | 2013 | 522 | 0.080 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 3694 | 0.070 |
Why?
|
Middle Aged | 10 | 2024 | 219653 | 0.070 |
Why?
|
United States | 9 | 2023 | 72237 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12522 | 0.070 |
Why?
|
Female | 15 | 2024 | 390240 | 0.070 |
Why?
|
Medication Errors | 1 | 2013 | 781 | 0.070 |
Why?
|
Documentation | 1 | 2013 | 885 | 0.070 |
Why?
|
Suicide | 1 | 2018 | 1599 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1533 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 64879 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4025 | 0.060 |
Why?
|
Medication Adherence | 1 | 2017 | 2161 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3416 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10734 | 0.060 |
Why?
|
Glioma | 1 | 2019 | 3414 | 0.060 |
Why?
|
Dementia | 1 | 2018 | 2634 | 0.060 |
Why?
|
Aged | 10 | 2024 | 168617 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3368 | 0.060 |
Why?
|
Salts | 1 | 2023 | 64 | 0.050 |
Why?
|
Adult | 8 | 2024 | 219390 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3605 | 0.050 |
Why?
|
Odds Ratio | 3 | 2020 | 9711 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3762 | 0.050 |
Why?
|
Amphetamine | 1 | 2023 | 224 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5131 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5796 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39216 | 0.050 |
Why?
|
Databases, Factual | 3 | 2021 | 8000 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1613 | 0.040 |
Why?
|
Age Factors | 3 | 2021 | 18394 | 0.040 |
Why?
|
Drugs, Generic | 1 | 2023 | 448 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 24049 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2018 | 628 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1078 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2024 | 1387 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7790 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2019 | 737 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 844 | 0.030 |
Why?
|
Arthritis | 1 | 2020 | 666 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1521 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13309 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58867 | 0.030 |
Why?
|
Immunotherapy | 2 | 2019 | 4622 | 0.030 |
Why?
|
Hypertension | 1 | 2013 | 8594 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2018 | 821 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2616 | 0.030 |
Why?
|
Medication Systems, Hospital | 1 | 2013 | 154 | 0.030 |
Why?
|
Adolescent | 3 | 2018 | 87560 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2018 | 2058 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2013 | 289 | 0.020 |
Why?
|
Medicare | 2 | 2019 | 6763 | 0.020 |
Why?
|
Young Adult | 2 | 2017 | 58483 | 0.020 |
Why?
|
Models, Statistical | 1 | 2024 | 5066 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3205 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2035 | 0.020 |
Why?
|
Medicaid | 1 | 2023 | 2808 | 0.020 |
Why?
|
Child | 2 | 2018 | 79623 | 0.020 |
Why?
|
Health Policy | 1 | 2021 | 2676 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10827 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1849 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11123 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2013 | 1161 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9269 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8609 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11653 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29561 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13621 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35941 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41935 | 0.010 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_